Accidental alcohol ingestion triggering severe disulfiram-like reaction in a child receiving cefoperazone-sulbactam: a rare case report. [PDF]
He H, Peng M, Liu X, Chen J, Ma L.
europepmc +1 more source
Evolution of cefoperazone-sulbactam consumption in Romania between 2011 and 2024. [PDF]
Vasile CC +3 more
europepmc +1 more source
Comparative analysis of treatment outcomes and risk factors associated with different combination antimicrobial regimens in patients with multidrug-resistant Acinetobacter baumannii pneumonia. [PDF]
Xu M, Liu M, Tang X, Wu X.
europepmc +1 more source
Salvage Treatment of Ventilator-Associated Pneumonia Using Sulbactam-Durlobactam in a Preterm Neonate: A Case Report. [PDF]
Zivojinovic S +7 more
europepmc +1 more source
Editorial: Clinical Guidelines and Real Practice of Antimicrobial Pharmacotherapy. [PDF]
Modun D.
europepmc +1 more source
Contribution of Acinetobacter-Derived Cephalosporinase-30 to Sulbactam Resistance in Acinetobacter baumannii [PDF]
The sulbactam resistance rate in Acinetobacter baumannii has increased worldwide. Previous reports have shown that the β-lactamase blaTEM-1 confers resistance to sulbactam in A. baumannii.
Shu-Chen Kuo +2 more
exaly +5 more sources
Sulbactam is one of four β-lactamase inhibitors in current clinical use to counteract drug resistance caused by degradation of β-lactam antibiotics by these bacterial enzymes. As a β-lactam itself, sulbactam is susceptible to degradation by β-lactamases.
Adam B Shapiro
exaly +2 more sources
Synergic In-Vitro Activity of Imipenem and Sulbactam Against Acinetobacter baumannii
The interaction between sulbactam and imipenem was evaluated with four clinical isolates of Acinetobacter baumannii, including two isolates resistant to imipenem, one of which produced IMP-1 metallo-beta-lactamase. Two isolates (one of which was imipenem-
Ja Young Choi +2 more
exaly +3 more sources
Objectives: This study aims to assess the in vitro activity of cefoperazone alone and different cefoperazone-sulbactam ratios against different inoculum sizes of multidrug resistant organisms.
Chuang Yin-ching +2 more
exaly +2 more sources
Related searches:
Sulbactam/ampicillin was recently marketed for use in several infections caused by beta-lactamase-producing organisms. Sulbactam is the second beta-lactamase inhibitor to become available in the United States. Interest in inhibition of beta-lactamases arose in the late 1960s when a combination consisting of an antibacterial agent and an enzyme ...
openaire +1 more source

